Clorox Co-The (CLX) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$1.65	$1.66	+0.6%	—	—	—
Q4 26	$1.54	$1.64	+6.5%	—	—	—
Q3 26	$1.43	$1.39	-2.8%	—	—	—
Q2 26	$0.78	$0.85	+9.0%	—	—	—
Q1 26	$2.21	$2.87	+29.9%	—	—	—
Q4 25	$1.56	$1.45	-7.1%	—	—	—
Q3 25	$1.4	$1.55	+10.7%	—	—	—
Q2 25	$1.39	$1.86	+33.8%	—	—	—
Q1 25	$1.55	$1.82	+17.4%	—	—	—
Q4 24	$1.37	$1.71	+24.8%	—	—	—
Q3 24	$1.1	$2.16	+96.4%	—	—	—
Q2 24	-$0.22	$0.49	+322.7%	—	—	—
Q1 24	$1.18	$1.67	+41.5%	—	—	—
Q4 23	$1.22	$1.51	+23.8%	—	—	—
Q3 23	$0.65	$0.98	+50.8%	—	—	—
Q2 23	$0.74	$0.93	+25.7%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$4.82	—	—	$6.7B	—
FY25	—	—	—	—	$7.1B	—
FY24	—	$2.26	—	—	$7.1B	—
FY23	—	$1.21	—	—	$7.4B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$6B	$6.1B	$6.2B	$6.7B	$7.3B	$7.1B	$7.4B	$7.1B	$7.1B	$6.7B
YoY change	+3.68%	+2.53%	+1.47%	+8.16%	+9.22%	-3.19%	+3.97%	-4.01%	+0.16%	-5.41%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	6B	6.1B	6.2B	6.7B	7.3B	7.1B	7.4B	7.1B	7.1B	6.7B
Cost of revenue	3.3B	3.4B	3.5B	3.7B	4.1B	4.6B	4.5B	4B	3.9B	3.9B
Gross profit	2.7B	2.7B	2.7B	3.1B	3.2B	2.5B	2.9B	3B	3.2B	2.8B
Gross margin	44.7%	43.7%	43.9%	45.6%	43.6%	35.8%	39.4%	43%	45.2%	42.3%
Research & development	135M	132M	136M	145M	149M	132M	138M	126M	121M	116M
Selling, general & administrative	1.4B	1.4B	1.5B	1.6B	1.8B	1.7B	1.9B	2.2B	1.9B	1.8B
Operating expenses	1.5B	1.5B	1.6B	1.8B	1.9B	1.8B	2.1B	2.3B	2B	1.9B
Operating income	1.1B	1.1B	1.1B	1.3B	1.2B	719M	823M	723M	1.2B	886M
Operating margin	18.7%	18.4%	17.8%	18.8%	16.7%	10.1%	11.1%	10.2%	16.6%	13.2%
Non-operating income, net	—	8M	11M	21M	-231M	-11M	-511M	-258M	-20M	27M
Pretax income	1B	1.1B	1B	1.2B	900M	607M	238M	398M	1.1B	791M
Income tax	330M	231M	204M	246M	181M	136M	77M	106M	254M	190M
Net income	701M	823M	820M	939M	719M	471M	161M	292M	824M	601M
Net margin	11.7%	13.4%	13.2%	14%	9.79%	6.63%	2.18%	4.12%	11.6%	8.94%
EBITDA	1.3B	1.3B	1.3B	1.5B	1.4B	947M	1.1B	968M	1.4B	1.1B
EPS	5.43	6.37	6.42	7.46	5.66	3.75	1.21	2.26	—	4.82
Diluted EPS	5.33	6.26	6.32	7.36	5.58	3.73	1.2	2.25	—	4.81

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	1.4B	2B	1.8B	1.9B	1.8B	1.7B	1.7B	2B	1.4B	1.7B	1.7B	1.9B
Cost of revenue	854M	1.1B	1B	1B	955M	948M	924M	1.1B	833M	951M	948M	1.1B
Gross profit	532M	866M	766M	884M	807M	738M	744M	924M	596M	722M	722M	804M
Gross margin	38.4%	43.5%	42.2%	46.5%	45.8%	43.8%	44.6%	46.5%	41.7%	43.2%	43.2%	41.3%
Research & development	29M	32M	32M	33M	31M	31M	27M	32M	28M	29M	27M	32M
Selling, general & administrative	441M	508M	516M	534M	482M	471M	474M	467M	443M	452M	406M	514M
Operating expenses	470M	540M	548M	567M	513M	502M	501M	499M	471M	481M	433M	546M
Operating income	62M	326M	218M	288M	294M	231M	238M	420M	120M	236M	284M	246M
Operating margin	4.47%	16.4%	12%	15.1%	16.7%	13.7%	14.3%	21.1%	8.4%	14.1%	17%	12.6%
Non-operating income, net	-12M	-164M	-238M	-15M	-96M	26M	37M	10M	8M	3M	-5M	21M
Pretax income	29M	136M	-42M	275M	177M	237M	254M	410M	107M	215M	256M	213M
Income tax	4M	40M	8M	54M	74M	43M	63M	74M	25M	54M	65M	46M
Net income	25M	96M	-50M	221M	103M	194M	191M	336M	82M	161M	191M	167M
Net margin	1.8%	4.82%	-2.76%	11.6%	5.85%	11.5%	11.5%	16.9%	5.74%	9.62%	11.4%	8.57%
EBITDA	111M	390M	278M	360M	370M	292M	333M	412M	178M	292M	346M	331M
EPS	0.17	0.75	-0.41	1.74	0.8	1.55	1.51	2.7	0.65	1.29	1.54	—
Diluted EPS	0.17	0.75	-0.41	1.73	0.8	1.54	1.5	2.68	0.65	1.29	1.54	—

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	17.2B	17.5B	19.6B	27.6B	22.6B	17.4B	19.7B	16.9B	—	11.6B	9.8B
Enterprise value	19B	19.8B	22.1B	29.9B	25.4B	20.3B	22.2B	19.6B	—	17B	15.8B
Shares outstanding	129M	129.3M	127.7M	125.8M	125.6M	123.1M	123.6M	124.2M	—	121.8M	121.8M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	24.5	21.2	23.9	29.4	31.4	36.9	122.1	58	—	19.3	16.9
P/S	2.88	2.86	3.15	4.11	3.08	2.44	2.66	2.39	—	1.73	1.47
P/B	31.7	24.1	35	30.4	38.2	23.8	50.7	34.4	—	46.1	109.4
EV/EBITDA	14.6	15.2	17	20.5	17.7	21.4	21	20.3	—	14.8	13.8
EV/Sales	3.17	3.24	3.56	4.44	3.47	2.85	3.01	2.77	—	2.53	2.34
Earnings yield	4.08%	4.71%	4.19%	3.4%	3.18%	2.71%	0.82%	1.72%	—	5.17%	5.91%
FCF yield	3.69%	4.47%	4.02%	4.68%	4.18%	3.08%	4.73%	2.85%	—	3.48%	1.12%
PEG	—	—	—	—	—	—	—	—	—	—	13

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	44.7%	43.7%	43.9%	45.6%	43.6%	35.8%	39.4%	43%	45.2%	42.3%	41.3%
Operating margin	18.7%	18.4%	17.8%	18.8%	16.7%	10.1%	11.1%	10.2%	16.6%	13.2%	12.9%
Net margin	11.7%	13.4%	13.2%	14%	9.79%	6.63%	2.18%	4.12%	11.6%	8.94%	8.73%
ROE	129.3%	113.4%	146.7%	103.4%	121.5%	64.6%	41.5%	59.3%	171%	238.5%	163.8%
ROA	15.3%	16.3%	16%	15.1%	11.4%	7.65%	2.71%	5.08%	14.8%	7.71%	8.32%
ROIC	32.8%	28.5%	28.3%	31.6%	28.5%	15.3%	18.9%	16.6%	28.2%	12%	12%
Return on tangible assets	95.1%	-41.1K%	745.5%	73.9%	53.3%	37%	7.98%	15.1%	41.8%	84.2%	84.2%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	0.84	1.09	0.91	1.42	0.89	0.97	0.95	1.03	0.84	0.66	0.66
Quick ratio	0.58	0.67	0.55	1.1	0.52	0.54	0.59	0.63	0.57	0.38	0.38
Debt / equity	4.05	3.42	4.8	3.44	5.35	4.26	7.54	5.9	5.98	21.9	22.2
Debt / assets	0.48	0.49	0.52	0.5	0.5	0.5	0.49	0.5	0.52	0.71	0.71
Net debt / EBITDA	1.37	1.8	1.98	1.55	1.98	3.08	2.41	2.79	1.91	4.69	4.69
Interest coverage	12.7	13.4	11.6	13	10.1	6.73	3.64	5.42	13.3	7.08	7.08
Effective tax rate	31.9%	21.9%	19.9%	20.8%	20.1%	22.4%	32.4%	26.6%	23.6%	24%	24%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	46.3	47.4	48.6	53.4	58.5	57.7	59.8	57.1	—	55.2	55.2
EPS (basic)	5.43	6.37	6.42	7.46	5.66	3.75	1.21	2.26	—	4.82	4.82
EPS (diluted)	5.33	6.26	6.32	7.36	5.58	3.73	1.2	2.25	—	4.81	4.81
Book value per share	4.2	5.62	4.38	7.22	4.71	5.92	3.14	3.96	—	2.07	0.74
FCF per share	4.92	6.05	6.15	10.3	7.53	4.35	7.52	3.89	—	3.33	0.91
Cash per share	3.24	1.01	0.87	6.92	2.54	1.49	2.97	1.63	—	1.17	1.18
Capex per share	—	—	—	—	—	—	—	—	—	1.7	1.7

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	—	—	—	—	—	—	—	—	3.1%	3.08%	3.08%
Capex / operating cash flow	—	—	—	—	—	—	—	—	22.4%	33.8%	33.8%
Payout ratio	58.8%	54.7%	59.8%	56.8%	77.6%	121.2%	362.1%	203.8%	73.1%	100.2%	103.1%
Dividend yield	2.4%	2.57%	2.51%	1.93%	2.47%	3.29%	2.97%	3.51%	—	5.18%	6.14%

Yield

6.14%

trailing twelve months

Frequency

Quarterly

Last dividend

$1.25

ex-dividend Aug 12, 2026

Payout ratio

103%

of earnings

Dividend growth

15 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 12, 2026	$1.25
Apr 22, 2026	$1.24
Jan 28, 2026	$1.24

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	$1.4B	$2B	$1.8B	$1.9B	$1.8B	$1.7B	$1.7B	$2B	$1.4B	$1.7B	$1.7B	$1.9B
YoY change	-20.3%	+16%	-5.27%	-5.75%	+27.1%	-15.3%	-8.05%	+4.47%	-18.9%	-0.77%	+0.12%	-2.01%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	418M	131M	111M	871M	319M	183M	367M	202M	167M	143M
Receivables	565M	600M	631M	648M	604M	681M	688M	695M	805M	769M
Inventory	459M	506M	512M	454M	752M	755M	696M	637M	523M	777M
Total current assets	1.5B	1.3B	1.3B	2B	1.8B	1.7B	1.8B	1.6B	1.6B	1.8B
Property, plant & equipment	407M	422M	438M	752M	927M	947M	881M	859M	801M	1B
Goodwill & intangibles	3.8B	5.1B	5B	4.9B	5B	4.9B	3.9B	3.8B	3.6B	7.1B
Total assets	4.6B	5.1B	5.1B	6.2B	6.3B	6.2B	5.9B	5.8B	5.6B	7.8B
Accounts payable	501M	507M	507M	575M	930M	960M	1B	950M	838M	996M
Short-term debt	804M	199M	396M	64M	381M	315M	137M	88M	91M	1.2B
Total current liabilities	1.8B	1.2B	1.4B	1.4B	2.1B	1.8B	1.9B	1.6B	1.9B	2.8B
Long-term debt	1.4B	2.3B	2.3B	3.1B	2.8B	2.8B	2.8B	2.8B	2.8B	4.3B
Total liabilities	4B	4.3B	4.6B	5.3B	5.7B	5.4B	5.6B	5.3B	5.1B	7.5B
Shareholders' equity	542M	726M	559M	908M	592M	729M	388M	492M	482M	252M
Total debt	2.2B	2.5B	2.7B	3.1B	3.2B	3.1B	2.9B	2.9B	2.9B	5.5B
Net debt	1.8B	2.4B	2.6B	2.3B	2.8B	2.9B	2.6B	2.7B	2.7B	5.4B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	518M	355M	219M	202M	278M	290M	226M	167M	166M	227M	1.2B	143M
Receivables	581M	679M	673M	695M	595M	603M	597M	805M	703M	671M	671M	769M
Inventory	710M	655M	674M	637M	594M	592M	635M	523M	577M	608M	588M	777M
Total current assets	1.9B	1.8B	1.7B	1.6B	1.6B	1.6B	1.6B	1.6B	1.7B	1.7B	2.7B	1.8B
Property, plant & equipment	1.6B	1.7B	1.7B	859M	1.6B	1.6B	1.6B	801M	1.6B	1.6B	1.6B	1B
Goodwill & intangibles	3.9B	3.9B	3.8B	3.8B	3.6B	3.6B	3.6B	3.6B	3.6B	3.6B	3.6B	7.1B
Total assets	6B	5.9B	5.8B	5.8B	5.5B	5.6B	5.5B	5.6B	5.5B	5.6B	6.4B	7.8B
Accounts payable	1.7B	1.6B	1.7B	950M	1.5B	1.5B	2B	838M	1.9B	2B	1.5B	996M
Short-term debt	435M	339M	193M	88M	87M	270M	139M	91M	307M	390M	1.7B	1.2B
Total current liabilities	2.2B	2B	1.8B	1.6B	1.6B	1.7B	2.2B	1.9B	2.2B	2.3B	3.2B	2.8B
Long-term debt	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B	4.3B
Total liabilities	5.9B	5.7B	5.5B	5.3B	5.3B	5.5B	5.3B	5.1B	5.4B	5.6B	6.3B	7.5B
Shareholders' equity	131M	218M	255M	492M	224M	121M	190M	482M	138M	35M	92M	252M
Total debt	3.2B	3.1B	3B	2.9B	2.9B	3.1B	2.9B	2.9B	3.1B	3.2B	4.5B	5.5B
Net debt	2.7B	2.8B	2.8B	2.7B	2.6B	2.8B	2.7B	2.7B	2.9B	3B	3.3B	5.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	703M	823M	820M	939M	719M	471M	161M	292M	824M	601M
Depreciation & amortization	163M	166M	180M	180M	211M	224M	236M	235M	219M	247M
Stock-based compensation	51M	53M	43M	50M	50M	52M	73M	74M	81M	48M
Change in working capital	-42M	-91M	4M	347M	19M	-115M	355M	-266M	-202M	116M
Operating cash flow	873M	972M	998M	1.5B	977M	656M	714M	261M	981M	612M
Capital expenditure	—	—	—	—	—	—	—	—	-220M	-207M
Investing cash flow	26M	-665M	10M	2M	-121M	22M	5M	37M	-94M	-2.3B
Dividends paid	-412M	-450M	-490M	-533M	-558M	-571M	-583M	-595M	-602M	-602M
Share repurchases	-183M	-271M	-661M	-248M	-905M	-25M	0	0	-332M	-256M
Financing cash flow	-720M	-444M	-773M	-685M	-1.5B	-694M	-786M	-656M	-950M	1.7B
Net change in cash	179M	-137M	235M	861M	-638M	-16M	-67M	-358M	-63M	2M
Free cash flow	634M	782M	786M	1.3B	945M	535M	930M	483M	761M	405M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	25M	96M	-50M	221M	103M	194M	191M	336M	82M	161M	191M	167M
Depreciation & amortization	61M	57M	58M	59M	54M	53M	55M	57M	56M	55M	58M	78M
Stock-based compensation	13M	16M	26M	19M	13M	27M	24M	17M	10M	24M	15M	-1M
Change in working capital	85M	-116M	-109M	14M	120M	-84M	-35M	-79M	-46M	22M	39M	63M
Operating cash flow	180M	5M	-131M	347M	284M	182M	224M	294M	93M	311M	-122M	330M
Capital expenditure	—	—	—	—	—	—	—	-75M	-36M	-42M	-43M	-86M
Investing cash flow	1M	19M	17M	0	128M	0	0	-76M	-34M	-43M	-43M	-2.2B
Dividends paid	-149M	-149M	-148M	-149M	-151M	-151M	-150M	-150M	-151M	-151M	-150M	-150M
Share repurchases	0	—	—	—	-107M	-150M	0	-75M	-129M	-127M	0	0
Financing cash flow	149M	-252M	-282M	-255M	-258M	-117M	-284M	-275M	-66M	-189M	1.1B	-653M
Net change in cash	330M	-228M	-396M	92M	154M	65M	-60M	-57M	-7M	79M	963M	-2.5B
Free cash flow	-4M	101M	127M	259M	182M	127M	233M	219M	57M	269M	-165M	244M

Date	Ratio
Aug 24, 1999	2:1
Sep 3, 1997	2:1
Jun 2, 1987	2:1

Clorox Co-The Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history